Fig. 2From: External validation of the European risk assessment tool for chronic cardio-metabolic disorders in a Middle Eastern populationThe incidence of chronic cardiometabolic disease in the development data (Netherlands), AusDiab (Australia), and TLGS (Tehran Lipid and glucose study). T2DM: type 2 diabetes; CKD: chronic kidney disease; CVD: cardiovascular diseaseBack to article page